ID   Ma-Mel-45b
AC   CVCL_C262
DR   cancercelllines; CVCL_C262
DR   Cosmic; 1846626
DR   Cosmic; 2686411
DR   ESTDAB; ESTDAB-193
DR   Wikidata; Q54903802
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-193
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 9,13
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A180 ! Ma-Mel-45a
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=23348503; DOI=10.1126/science.1230062;
RA   Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A.,
RA   Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R.;
RT   "TERT promoter mutations in familial and sporadic melanoma.";
RL   Science 339:959-961(2013).
//